(Q31015085)

28 June 2017

title

Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists (English)

1 reference

28 June 2017

Barrow JC

1

1 reference

28 June 2017

Nantermet PG

2

1 reference

28 June 2017

Selnick HG

3

1 reference

28 June 2017

Glass KL

4

1 reference

28 June 2017

Ngo PL

5

1 reference

28 June 2017

Young MB

6

1 reference

28 June 2017

Pellicore JM

7

1 reference

28 June 2017

Breslin MJ

8

1 reference

28 June 2017

Hutchinson JH

9

1 reference

28 June 2017

Freidinger RM

10

1 reference

28 June 2017

Condra C

11

1 reference

28 June 2017

Karczewski J

12

1 reference

28 June 2017

Bednar RA

13

1 reference

28 June 2017

Gaul SL

14

1 reference

28 June 2017

Stern A

15

1 reference

28 June 2017

Gould R

16

1 reference

28 June 2017

Connolly TM

17

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

28 June 2017

number of pages

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

28 June 2017

volume

11

1 reference

28 June 2017

issue

20

1 reference

28 June 2017

page(s)

2691-2696

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

28 June 2017

1 reference

7 January 2021

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

How the protease thrombin talks to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

The protease-activated receptors and their cellular expression and function in blood-related cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Cellular consequences of thrombin-receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Thrombin signalling and protease-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Protease activated receptors: theme and variations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Thrombin receptor: a novel target for antiplatelet drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Development of a potent thrombin receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Development of potent thrombin receptor antagonist peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

Oxygen isosteric derivatives of 3-(3-hydroxyphenyl)-N-n-propylpiperidine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900538-8

7 January 2021

10.1016/S0960-894X(01)00538-8

Identifiers

DOI

1 reference

28 June 2017

1 reference